Non-competitive inhibition Information & Non-competitive inhibition Links at HealthHaven.com

Non-competitive inhibition is a type of enzyme inhibition that reduces the maximum rate of a chemical reaction (V_max) without changing the apparent binding affinity of the catalyst for the substrate (K_mApp in the case of enzyme inhibition, – see Michaelis-Menten kinetics).

Non-competitive inhibition usually applies to enzymes and differs from competitive inhibition in that the inhibitor always binds to the enzyme at a site other than the enzyme's active site (this other site is called an allosteric site). This affects the rate of the reaction catalysed by the enzyme because the presence of the inhibitor causes a change in the structure and shape of the enzyme. This change in shape means the enzyme is no longer able to bind with a substrate correctly (See lock and key hypothesis). This reduces the concentration of 'active' enzyme resulting in a decrease in the V_max. In this mode of inhibition, there is no competition between the inhibitor and the substrate, so increasing the concentration of the substrate still does not allow the maximum enzyme activity rate to be reached.

[edit] Note

Although non-competitive inhibition generally implies that the inhibitor does not bind to the active site of the enzyme, the converse is not true: Competitive inhibition can either be due to competition for the binding site, or by allosteric competitive inhibition. For simple Michaelis-Menten kinetics, the apparent maximum reaction rate is as follows:

${apparent\ k}_2=\frac{k_2}{1+\frac{[I]}{K_I}}$

$V_{max}=k_2[E_0]=\frac{k_2 \times E_0}{1+\frac{[I]}{K_I}}$

[edit] Example: noncompetitive inhibitors of CYP2C9 enzyme

Noncompetitive inhibitors of CYP2C9 enzyme include nifedipine, tranylcypromine, phenethyl isothiocyanate, medroxyprogesterone acetate and 6-hydroxyflavone. Computer docking simulation and constructed mutants substituted indicate that the noncompetitive binding site of 6-hydroxyflavone is the reported allosteric binding site of CYP2C9 enzyme^[1].

[edit] References

^ Si Dayong, Wang Y, Guo Y, Wang J, Zhou H, Zhou Y-H, Li Z-S, Fawcett JP (2008). Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug Metabolism and Disposition. doi:10.1124/dmd.108.023416[1]

This biochemistry article is a stub. You can help Wikipedia by expanding it.

[0] Si Dayong, Wang Y, Guo Y, Wang J, Zhou H, Zhou Y-H, Li Z-S, Fawcett JP (2008). Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug Metabolism and Disposition. doi:10.1124/dmd.108.023416[1]

[1]